NEW GROWTH EQUATION FOR PREMATURE INFANTS. 1363
نویسندگان
چکیده
منابع مشابه
A growth chart for premature and other infants.
Gairdner, D., and Pearson, J. (1971). Archives of Disease in Childhood, 46, 783. A growth chart for premature and other infants. The growth chart covers the period from 28 weeks of fetal life to age 2 years, and allows weight, length, and head circumference to be charted. The time scale is logarithmic, providing the convenience of an extended scale for the earlier months of life, and giving the...
متن کاملSlow to change: new cord clamping policies for premature infants.
Recently, the American College of Obstetricians & Gynecologists (ACOG) recommended a 30–60 second delay in umbilical cord clamping for all preterm deliveries [1]. Delayed cord clamping in preterm infants has been associated with a greater than 50% reduction in intraventricular hemorrhage and less need for blood transfusions as demonstrated in a recent Cochrane meta-analysis of 10 randomized con...
متن کاملGrowth rate of corpus callosum in very premature infants.
BACKGROUND AND PURPOSE It is desirable to develop a bedside method for assessing cerebral development in the very premature infant to monitor the effectiveness of interventions aimed at improving cerebral development. Our aim was to describe the growth trajectory of the corpus callosum (CC) on cranial sonography in very premature infants. METHODS We recruited 100 very-low-birth-weight infants...
متن کاملBronchopulmonary dysplasia and postnatal growth in extremely premature black infants.
Bronchopulmonary dysplasia (BPD) may adversely affect the postnatal growth of the extremely premature infant; however, most studies have not controlled for birth weight. We studied 90 Black premature infants (mean birth weight 989 +/- 148 g). Weight was recorded biweekly until discharge and at 4, 8, and 12 months of age corrected for prematurity. Infants with BPD (N = 23) were contrasted with i...
متن کاملMicafungin in Premature and Non-premature Infants
BACKGROUND Invasive fungal infections cause excessive morbidity and mortality in premature neonates and severely ill infants. METHODS Safety and efficacy outcomes of micafungin were compared between prematurely and non-prematurely born infants <2 years of age. Data were obtained from all completed phase I-III clinical trials with micafungin that had enrolled infants (<2 years of age) that wer...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1996
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-199604001-01386